id: opioid_epidemic_prevalence_to_polypharmacy_abuse_risk
name: Opioid Epidemic Prevalence â†’ Polypharmacy Abuse Risk
from_node:
  node_id: opioid_epidemic_prevalence
  node_name: Opioid Epidemic Prevalence
to_node:
  node_id: polypharmacy_abuse_risk
  node_name: Polypharmacy Abuse Risk
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Increasing prevalence of opioid epidemic leads to more patients requiring
  opioid use disorder treatment'
- 'Step 2: Clonidine is commonly used to treat or prevent withdrawal in patients with
  opioid use disorders'
- 'Step 3: Higher volume of concurrent medication availability creates more opportunities
  for combined substance abuse patterns'
- 'Step 4: Healthcare providers must prescribe multiple psychoactive agents, increasing
  complexity of abuse potential monitoring'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Brian G Mitchell and Jaekyu Lee 2021. "Case Report: Concurrent
    Clonidine Abuse and Opioid Use Disorder.." *Journal of psychoactive drugs*. https://doi.org/10.1080/02791072.2021.1908644'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.754764'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: provider_vigilance
  direction: weakens
  strength: moderate
  description: Increased vigilance in prescribing practices and monitoring of psychoactive
    pharmacologic agents can reduce polypharmacy abuse risk
- name: treatment_access
  direction: strengthens
  strength: moderate
  description: Limited access to comprehensive addiction treatment services may increase
    reliance on pharmacologic management with multiple agents
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/opioid_epidemic_prevalence_to_polypharmacy_abuse_risk.yaml
_category: healthcare_access
